July 17, 2006

1. Adverse events in cord blood transplantation (Category XIV, i – Infections other than EBV).

1. Update on management of infections in cancer and stem cell transplant patients - a detailed review.
2. Severe infections after unrelated HSCT: A comparison of UCBT with PBSC transplantation and BMT.

2. Adverse events in cord blood transplantation. (Category XIV, ii - EBV infections)

1. Marked increased risk of EBV-related complications with the addition of ATG to non-myeloablative conditioning prior to unrelated UCBT (Citation #1).
2. A review of post-transplant lymphoproliferative disease (PTLD) (Citation #2).
3. Efficacy and safety of rituximab in PTLD (Citation #3).
4. PTLD after UCBT in children (Citation #4).

3. A review of hematopoietic stem-cell transplantation, with comments about UCBT and the fact that HSCT is underutilized. (Category I, Citation #10)

4. Transplantation of Adults (Category II)

1. Unrelated UCBT in adults with hematologic malignancies – outcomes in 171 patients with comments about comparable results in BMT (Citation #5)
2. Unrelated UCBT for myelodysplastic syndrome (Citation #8).
3. UCBT for adults with hematologic malignancies – a report from Australia (Citation #10)

5. Reduced-intensity and non-myeloablative transplants (Category IV)

1. Comparable results of UCBT and HLA-matched sibling transplants after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.

6. UCBT in children (Category VII).

1. Results of a COBLT study of Unrelated UCBT for lysosomal and peroxisomal storage diseases (Category VII, ii. congenital disorders, Citation #5)
2. UCBT for Evans syndrome (Category VII, iii acquired non-malignant disorders, Citation #1)

7. New concepts in cord blood transplantation (Category XV, ii. Co-transplantation of CBU and mobilized stem cells from a third party donor).

1. Single unit UCBT in adults followed by co-infusion of mobilized stem cells from a third party to produce early hematopoietic recovery (Citation B)